Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 14, 2018)
  • 8-K (Jan 29, 2018)
  • 8-K (Jan 4, 2018)
  • 8-K (Nov 9, 2017)
  • 8-K (Sep 22, 2017)
  • 8-K (Aug 8, 2017)

 
Other

CAS Medical Systems 8-K 2017

Documents found in this filing:

  1. 8-K
  2. 8-K

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549
 

FORM 8-K

 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  June 21, 2017
 


CAS MEDICAL SYSTEMS, INC.
(Exact name of Registrant as specified in its charter)


Delaware
(State or other jurisdiction
of incorporation)
0-13839
(Commission File Number)
06-1123096
(I.R.S. Employer
Identification No.)
 
44 East Industrial Road, Branford, Connecticut 06405
(Address of principal executive offices, including zip code)
 
(203) 488-6056
(Registrant's telephone number, including area code)
 

 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
 

 
 
Item 5.07 Submission of Matters to a Vote of Security Holders.

At the annual meeting of stockholders of CAS Medical Systems, Inc. (the "Company") held on June 21, 2017, three proposals were voted upon and approved by the Company's stockholders.  A brief description of each proposal voted upon at the annual meeting and the number of votes cast for, against, and withheld, as well as the number of abstentions and broker non-votes, where applicable, are set forth below.

(1) Election of seven members of the Board of Directors, each for a term of one year:

Nominee
For
Withheld
Broker
 Non-Votes
Alan W. Milinazzo
18,946,953
481,010
10,775,664
Paul A. Molloy
18,986,517
441,446
10,775,664
Thomas M. Patton
18,985,122
442,841
10,775,664
Gregory P. Rainey
18,978,492
449,471
10,775,664
James E. Thomas
18,976,617
451,346
10,775,664
Kathleen A. Tune
18,885,277
542,686
10,775,664
Kenneth R. Weisshaar
18,986,492
441,471
10,775,664


(2) Advisory approval of the compensation of the Company's named executive officers:

For
Against
Abstain
Broker Non-Votes
18,903,847
466,424
57,692
10,775,664
       


(3) Ratification of the appointment of CohnReznick LLP as auditor for the Company for the fiscal year ending December 31, 2017:

For
Against
Abstain
 
29,886,485
257,250
59,892
 
       
 
 
 
 

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
CAS MEDICAL SYSTEMS, INC.
 
       
       
       
Date:  June 22, 2017
By:
/s/ Jeffery A. Baird  
    Jeffery A. Baird  
    Chief Financial Officer  
       
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



3
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki